Nanocarriers in Prostate Cancer: Advanced Diagnosis and Treatment Strategies provides a comprehensive, up-to-date resource on the latest advancements in nanotechnology for prostate cancer therapy. Sections delve into different types of nanomaterials, including polymeric nanoparticles, DNA origami nanocarriers, and dendrimers. Each chapter explores their unique applications in targeted drug delivery, imaging, and therapeutic strategies, providing detailed insights into how nanotechnology revolutionizes prostate cancer care. This book benefits researchers, clinicians, and students focused on oncology and nanomedicine by offering a deep dive into the potential of nanocarriers in prostate cancer treatment.
This book bridges the gap between cutting-edge research and clinical applications, offering insights into how various nanocarriers enhance drug delivery, improve imaging techniques, and provide targeted, less invasive treatments. It serves as a valuable resource for developing more effective, personalized treatments, leading to improved patient outcomes and reduced toxicity associated with traditional therapies.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. Introduction2. Polymeric Nanoparticles: Advancing Prostate Cancer Treatment
3. Advances in silica-based nanoparticles for targeting prostate cancer
4. Breakthrough in magnetic nanoparticles for management of prostate cancer
5. Innovative approaches of metallic (gold, silver) nanoparticles in targeting of prostate cancer
6. Recent application of liposomes, niosomes and exosomes in precise targeting of prostate cancer
7. Therapeutic Potential of Dendrimers in Prostate Cancer: Advances and Challenges
8. Carbon Nanotubes in Prostate Cancer: Emerging Frontiers in Diagnosis and Therapy
9. Targeted therapy of quantum dots against prostate cancer
10. Nanoemulsions and Nanosuspensions: Innovative Nanocarrier Systems for Prostate Cancer Management
11. Nanogels in Prostate Cancer: A Novel Avenue for Targeted Therapy and Enhanced Drug Delivery
12. DNA Origami Nanocarriers: Revolutionizing Prostate Cancer Therapy
Authors
Bhupendra G. Prajapati Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, Gujarat, India. Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid-based formulations, nano- and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section-editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination. Devesh U. Kapoor Professor, Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, India. Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified-release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer-review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs. Nemat Ali King Saud University, Saudi Arabia.Currently working as an Assistant Professor in the Department of Pharmacology and Toxicology at College of Pharmacy King Saud University, Riyadh Saudi Arabia. Before joining King Saud University worked as a Post-Doctoral Scholar in the School of Medicine, University of Kentucky, Lexington, USA.. Currently involved in teaching, research, and research is mainly focused on finding the molecular mechanisms involved in cancer chemoprevention and chemotherapy-induced vital organ toxicity and their prevention using natural and synthetic compounds using in-vivo and in-vitro models. He has published more than 130 research, review and book chapters in highly reputed international journals.
Anand Krishnan Precision Medicine and Integrated Nano-Diagnostics (P-MIND) Research Group, Office of the Dean, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.Dr. Anand Krishnan, Principal Investigator in Chemical Pathology, Office of the Dean, Faculty of Health Sciences, University of the Free State, South Africa. He leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories, which focus on the biological functions of extracellular vesicles (EVs) in synthetic biology. His research encompasses cell surface protein modification, biomarker discovery through EVs derived from liquid biopsies, and the role of circulating biomarkers in disease development and stem cell biology. Dr. Krishnan has authored over 150 articles and edited eight books published by Elsevier, Springer, and Wiley. He received the National Research Foundation (NRF) rating for Next Generation Researchers in South Africa. In the latest list published by Stanford University, Dr. Krishnan was named among the Top 2% of the most influential scientists worldwide. He is an active member of the International Society of Extracellular Vesicles (ISEV), the African Organisation for Research and Training in Cancer (AORTIC), and the American Association of Cancer Research (AACR). Recently, he has been serving as an editor for the eLife journal, focusing on the Africa region.
